Scilex (SCLX) said Friday it will implement a 1-for-35 reverse stock split of its outstanding shares on April 15 following previous shareholder and board approval.
The reverse split is expected to help the pharmaceutical company regain compliance with Nasdaq's minimum share price requirement of $1 per share for continued listing, Scilex said.
The reverse split will reduce the number of issued and outstanding common shares to about 6.9 million from 243 million.
Shares will start trading on a split-adjusted basis on April 15.
SCLX shares were down 19.5% in recent Friday trading.
Price: 0.20, Change: -0.05, Percent Change: -19.53
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。